(a) The Department of Human Services shall ensure that the Arkansas Medicaid Program covers medications approved by the United States Food and Drug Administration for tobacco cessation, including without limitation:(1) Nicotine replacement therapy patches;(2) Nicotine replacement therapy gum;(3) Nicotine replacement therapy lozenges;(4) Nicotine replacement therapy nasal spray;(5) Nicotine replacement therapy inhalers;(6) Bupropion; and(7) Varenicline.
(1) Nicotine replacement therapy patches;
(2) Nicotine replacement therapy gum;
(3) Nicotine replacement therapy lozenges;
(4) Nicotine replacement therapy nasal spray;
(5) Nicotine replacement therapy inhalers;
(6) Bupropion; and
(7) Varenicline.
(b) Prior authorization shall not be required for coverage of medications described in subsection (a) of this section.